Filing Flows › Wave Life Sciences (WVE) › Q2 2026 › vs Q1 2026
Wave Life Sciences (WVE) Q2 2026 vs Q1 2026 (quarter over quarter)
Wave Life Sciences's revenue fell $36.0M (-94%) from $38.2M in Q1 2026 to $2.3M in Q2 2026.
Wave Life Sciences, Q2 2026: revenue $2.3M (-74% year over year), net loss $69.4M, operating cash flow −$53.6M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $2.3M | $38.2M | −$36.0M | -94% |
| Other income, net | $4.4M | $5.2M | −$764K | -15% |
| Net loss | $69.4M | $26.1M | $43.3M | +166% |
| Costs & expenses | $76.1M | $69.5M | $6.5M | +9% |
| Operating costs | $76.1M | $69.5M | $6.5M | +9% |
| Research & development | $51.3M | $47.4M | $3.9M | +8% |
| General & admin | $24.8M | $22.1M | $2.7M | +12% |
| Operating cash sources | $69.4M | $26.1M | $43.3M | +166% |
| Depreciation | $858K | $841K | $17K | +2% |
| Share-based compensation | $10.7M | $9.1M | $1.7M | +18% |
| Working capital & other | $4.2M | −$43.4M | $47.6M | — |
| Cash used in operations | $53.6M | $59.6M | −$6.0M | -10% |
| Net loss absorbed | $69.4M | $26.1M | $43.3M | +166% |
Questions
How much did Wave Life Sciences's revenue grow quarter over quarter in Q2 2026?
Wave Life Sciences's revenue fell $36.0M (-94%) from $38.2M in Q1 2026 to $2.3M in Q2 2026.